Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117832008 | 11783200 | 8 | F | 20160405 | 20160805 | 20151127 | 20160810 | EXP | PHHY2015CA151175 | NOVARTIS | 72.76 | YR | F | Y | 0.00000 | 20160810 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117832008 | 11783200 | 1 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 15 MG, BID | Y | 0 | 15 | MG | TABLET | BID | |||||
| 117832008 | 11783200 | 2 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 5 MG, BID | Y | 0 | 5 | MG | TABLET | BID | |||||
| 117832008 | 11783200 | 3 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 5 MG, BID TUESDAY, THURSDAY, SATURDAY AND SUNDAY | Y | 0 | 5 | MG | TABLET | BID | |||||
| 117832008 | 11783200 | 4 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 10 MG BID TUESDAY,THURSDAY,SATURDAY, 10 MG BID ON SUNDAY, I DF PER DAY ON MONDAY, WEDENSDAY, FRIDAY | Y | 0 | TABLET | ||||||||
| 117832008 | 11783200 | 5 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 20 MG, ON MONDAY, WEDNESDAY AND FRIDAY | Y | 0 | 20 | MG | TABLET | ||||||
| 117832008 | 11783200 | 6 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 5 MG, BID | Y | 0 | 5 | MG | TABLET | BID | |||||
| 117832008 | 11783200 | 7 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 15 MG, BID | Y | 0 | 15 | MG | TABLET | BID | |||||
| 117832008 | 11783200 | 8 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | 5 MG, BID | Y | 0 | 5 | MG | TABLET | BID | |||||
| 117832008 | 11783200 | 9 | PS | EXJADE | DEFERASIROX | 1 | Oral | 3500 MG, QD | Y | 21882 | 3500 | MG | DISPERSIBLE TABLET | QD | |||||
| 117832008 | 11783200 | 10 | SS | DESFERAL | DEFEROXAMINE MESYLATE | 1 | Intravenous (not otherwise specified) | QD | 0 | SOLUTION FOR INJECTION | QD | ||||||||
| 117832008 | 11783200 | 11 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | U | 0 | ||||||||||
| 117832008 | 11783200 | 12 | C | OMEGA 3 | OMEGA-3 FATTY ACIDS | 1 | Unknown | U | 0 | ||||||||||
| 117832008 | 11783200 | 13 | C | WATER PILLS | UNSPECIFIED INGREDIENT | 1 | Unknown | U | 0 | ||||||||||
| 117832008 | 11783200 | 14 | C | PREVACID | LANSOPRAZOLE | 1 | Unknown | U | 0 | ||||||||||
| 117832008 | 11783200 | 15 | C | RESTORALAX | POLYETHYLENE GLYCOL 3350 | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117832008 | 11783200 | 1 | Myelofibrosis |
| 117832008 | 11783200 | 9 | Myelofibrosis |
| 117832008 | 11783200 | 10 | Myelofibrosis |
| 117832008 | 11783200 | 11 | Product used for unknown indication |
| 117832008 | 11783200 | 12 | Product used for unknown indication |
| 117832008 | 11783200 | 13 | Product used for unknown indication |
| 117832008 | 11783200 | 14 | Product used for unknown indication |
| 117832008 | 11783200 | 15 | Constipation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117832008 | 11783200 | OT |
| 117832008 | 11783200 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117832008 | 11783200 | Abdominal discomfort | |
| 117832008 | 11783200 | Abdominal pain upper | |
| 117832008 | 11783200 | Amnesia | |
| 117832008 | 11783200 | Anaemia | |
| 117832008 | 11783200 | Aphasia | |
| 117832008 | 11783200 | Blood pressure decreased | |
| 117832008 | 11783200 | Confusional state | |
| 117832008 | 11783200 | Constipation | |
| 117832008 | 11783200 | Contusion | |
| 117832008 | 11783200 | Diarrhoea | |
| 117832008 | 11783200 | Dizziness | |
| 117832008 | 11783200 | Drug ineffective | |
| 117832008 | 11783200 | Dry skin | |
| 117832008 | 11783200 | Fatigue | |
| 117832008 | 11783200 | Flatulence | |
| 117832008 | 11783200 | Haemorrhoidal haemorrhage | |
| 117832008 | 11783200 | Haemorrhoids | |
| 117832008 | 11783200 | Headache | |
| 117832008 | 11783200 | Heart rate decreased | |
| 117832008 | 11783200 | Immune system disorder | |
| 117832008 | 11783200 | Laceration | |
| 117832008 | 11783200 | Lactose intolerance | |
| 117832008 | 11783200 | Liver disorder | |
| 117832008 | 11783200 | Muscle spasms | |
| 117832008 | 11783200 | Nausea | |
| 117832008 | 11783200 | Off label use | |
| 117832008 | 11783200 | Pain in extremity | |
| 117832008 | 11783200 | Palpitations | |
| 117832008 | 11783200 | Peripheral swelling | |
| 117832008 | 11783200 | Pruritus | |
| 117832008 | 11783200 | Rash | |
| 117832008 | 11783200 | Scab | |
| 117832008 | 11783200 | Splenomegaly | |
| 117832008 | 11783200 | Stomatitis | |
| 117832008 | 11783200 | Stress | |
| 117832008 | 11783200 | Swelling | |
| 117832008 | 11783200 | Urticaria | |
| 117832008 | 11783200 | Weight increased | |
| 117832008 | 11783200 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117832008 | 11783200 | 1 | 20150701 | 201508 | 0 | |
| 117832008 | 11783200 | 2 | 201509 | 0 | ||
| 117832008 | 11783200 | 9 | 20151113 | 20151210 | 0 |